Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad
Peter M
PM
Bolton, Salford & Trafford Mental Health NHS Trust, Salford, UK.
Wieck
Angelika
A
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D011388:Prolactin / Q000378:metabolism / Q000502:physiology; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D011388:Prolactin